Jurevicius J, Muckus K, Macianskiene R, Chmel-Dunaj G N
Laboratory of Membrane Biophysics, Z. Januskevicius Institute of Cardiology, Kansas, Lithuania, USSR.
J Mol Cell Cardiol. 1991 Feb;23 Suppl 1:103-14. doi: 10.1016/0022-2828(91)90029-l.
The effects of class I antiarrhythmic drugs (quinidine, lidocaine, ethmozin) on the maximum upstroke velocity (Vmax) of the action potential (AP) of guinea-pig papillary muscles were investigated in the presence and absence of nifedipine and a potassium-free solution. Nifedipine (10 microM) decreased AP duration from 208 +/- 13 ms to 148 +/- 17 ms (P less than 0.05, n = 4), but did not influence resting potential and Vmax. Removal of K+ from the perfusate increase the membrane potential from -86 +/- 4 mV to -103 +/- 7 mV (P less than 0.05, n = 4). Quinidine (20 microM) lidocaine (40 microM) and ethmozin (2 microM) decreased Vmax. Nifedipine and K(+)-free solution elevated Vmax when depressed by lidocaine and ethmozin. At 2 Hz rate of stimulation, Vmax increased from 69.5 +/- 12.0% to 76.0 +/- 10.6% and 98.5 +/- 3.2% (P less than 0.05, n = 7) for lidocaine and from 33.9 +/- 13.9% to 41.3 +/- 14.4% and 75.3 +/- 10.3% (P less than 0.05, n = 6) for ethmozin, compared to the control, when nifedipine or K(+)-solution was used, respectively. Nifedipine induced a slight decrease and potassium-free solution, a slight increase of Vmax in the case with quinidine from 49.9 +/- 11.8% to 48.8 +/- 7.2% and 52.7 +/- 6.7 (P greater than 0.05, n = 7), respectively. The time constant of recovery (tau r) from use-dependent block of Vmax decreased in K(+)-free solution containing lidocaine and ethmozin, but not quinidine. The guarded receptor hypothesis was used to stimulate the effects of these drugs. Our estimates of the drug affinities for activated, inactivated, and rested channels were: for quinidine 1.28 x 10(5), 1.15 x 10(4), 1.0 x 10(3); for lidocaine 1.7 x 10(4), 1.88 x 10(5) 2.5 x 10(1); and for ethmozin 1.5 x 10(6), 3.0 x 10(6), 1.5 x 10(4), respectively. The results suggest that the role of AP duration on lidocaine and ethmozin effectiveness is reduced when resting potential decreases and that removal of K+ from a perfusate containing. quinidine had a small effect on Vmax, despite a marked increase in AP duration and resting potential.
在存在和不存在硝苯地平和无钾溶液的情况下,研究了I类抗心律失常药物(奎尼丁、利多卡因、乙吗噻嗪)对豚鼠乳头肌动作电位(AP)最大上升速度(Vmax)的影响。硝苯地平(10微摩尔)使动作电位持续时间从208±13毫秒降至148±17毫秒(P<0.05,n = 4),但不影响静息电位和Vmax。从灌注液中去除钾使膜电位从-86±4毫伏升至-103±7毫伏(P<0.05,n = 4)。奎尼丁(20微摩尔)、利多卡因(40微摩尔)和乙吗噻嗪(2微摩尔)降低Vmax。当利多卡因和乙吗噻嗪使Vmax降低时,硝苯地平和无钾溶液可使其升高。在2赫兹刺激频率下,与对照组相比,当分别使用硝苯地平或无钾溶液时,利多卡因的Vmax从69.5±12.0%分别增至76.0±10.6%和98.5±3.2%(P<0.05,n = 7),乙吗噻嗪的Vmax从33.9±13.9%分别增至41.3±14.4%和75.3±10.3%(P<0.05,n = 6)。硝苯地平使奎尼丁存在时的Vmax略有降低,无钾溶液使其略有升高,分别从49.9±11.8%降至48.8±7.2%和升至52.7±6.7%(P>0.05,n = 7)。在含有利多卡因和乙吗噻嗪的无钾溶液中,Vmax从使用依赖性阻滞恢复的时间常数(τr)降低,但奎尼丁不存在这种情况。采用保护受体假说解释这些药物的作用。我们对这些药物与激活、失活和静息通道的亲和力估计分别为:奎尼丁1.28×10⁵、1.15×10⁴、1.0×10³;利多卡因1.7×10⁴、1.88×10⁵、2.5×10¹;乙吗噻嗪1.5×10⁶、3.0×10⁶、1.5×10⁴。结果表明,当静息电位降低时,动作电位持续时间对利多卡因和乙吗噻嗪有效性的作用减弱,并且从含有奎尼丁的灌注液中去除钾对Vmax影响较小,尽管动作电位持续时间和静息电位有明显增加。